Sunitha Chari, PhD
Sunitha earned her PhD in Biochemistry from Boston University where she investigated the molecular interactions between low-density lipoprotein receptor and its ligands. She completed her post doctoral training in structural biology and biochemistry at McGill University where she investigated the structure-function relationship of a protein complex involved in cellular transport. After her post-doc she transitioned to scientific communication. She has written on medical and scientific topics for pharma, and non-profit. Sunitha joined Drug Discovery News in November 2021 as Assistant Science Editor and enjoys the combination of intellectual rigour and creative flair her everyday work demands.
Articles by Sunitha Chari, PhD
Advanced techniques, tools, and strategies can help researchers refine their proteomics workflows, improving downstream results.
Different precision medicine approaches modulate distinct pathways to treat cancer, but how do scientists know which approach is best?
Advanced proteomics tools aid in biomarker discovery and pave the way for precision medicine.
Scientists fight against cancer progression using checkpoint inhibitor drugs.
Understanding the molecular pathology of leukemia guides researchers to develop targeted treatments.
Social interactions spark numerous biological processes that influence mental and physical health.
Scientists delve into the spatial context of cancer biology, opening new treatment avenues.
At the frontline of an autoimmune attack are rogue immune cells turned foe against the body they were created to protect. Scientists study the complex etiology of autoimmune disorders to restore the broken balance.
Proteomics technologies are poised to deliver on the promise of precision medicine.
Page 1 of 1 - 10 Total Items
